FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives

FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives / United States General Accounting Office.

Author/creator	Hamilton, Mary R.
Other author/creator	United States. General Accounting Office.
Format	Book and Microform
Publication Info	Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor], [1996]
Description	13 pages, 2 unnumbered pages : illustrations ; 28 cm.
Subject(s)	United States. Food and Drug Administration. Drugs--United States --Testing. Drugs--Law and legislation --United States.

Series	Testimony ; GAO/T-PEMD-96-9 Testimony GAO/T-PEMD-96-9. ^A682308
General note	Distributed to depository libraries in microfiche.
General note	Shipping list no.: 98-0141-M.
General note	"May 2, 1996."
Bibliography note	Includes bibliographical references.
Reproduction note	Joyner- Microfiche. [Washington, D.C] : U.S. General Accounting Office, [1996] 1 microfiche : negative.
GPO item number	0546-D-01 (MF)
Govt. docs number	GA 1.5/2:T-PEMD-96-9

Library	Location	Call Number	Status	Item Actions
Joyner	Microforms B300	GA 1.5/2:T-PEMD-96-9	✔ Available